The strongest evidence-based case for GLP-1 therapy is in patients who have both overweight or obesity and established cardiovascular disease
The injection helps support nerve function and relieve deficiency-related symptoms
Clinical trials and FDA labeling show eructation or burping occurs in approximately 3% of people taking Ozempic injection, up to 2% in people taking Rybelsus (rebranded to Ozempic pill), about 7% of those on Wegovy, and 25% with Mounjaro and Zepbound
You may call us at (646) 960-3080 or have your case reviewed by clicking here.
Benefits of a Comprehensive GLP-1 and Exercise Program By integrating strength training, balanced cardio, and mobility into your Wegovy workout plan or Zepbound exercise routine , you unlock a host of benefits that go far beyond the number on the scale: Sustainable Results: Youll be building a stronger, more efficient metabolism, which is the best defense against weight regain
Savings & Resources | Mounjaro (tirzepatide)